Amedisys EBITDA Margin 2010-2024 | AMED

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Amedisys (AMED) over the last 10 years. The current EBITDA margin for Amedisys as of March 31, 2024 is .
Amedisys EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $2.25B $0.21B 9.15%
2023-12-31 $2.24B $0.22B 9.66%
2023-09-30 $2.23B $0.23B 10.33%
2023-06-30 $2.23B $0.23B 10.32%
2023-03-31 $2.23B $0.24B 10.88%
2022-12-31 $2.22B $0.25B 11.34%
2022-09-30 $2.22B $0.26B 11.58%
2022-06-30 $2.22B $0.28B 12.42%
2022-03-31 $2.23B $0.30B 13.66%
2021-12-31 $2.23B $0.32B 14.55%
2021-09-30 $2.23B $0.34B 15.15%
2021-06-30 $2.22B $0.34B 15.49%
2021-03-31 $2.16B $0.32B 14.58%
2020-12-31 $2.11B $0.29B 13.63%
2020-09-30 $2.05B $0.26B 12.83%
2020-06-30 $2.00B $0.24B 12.12%
2020-03-31 $1.98B $0.24B 11.86%
2019-12-31 $1.96B $0.23B 11.91%
2019-09-30 $1.89B $0.22B 11.43%
2019-06-30 $1.81B $0.20B 10.93%
2019-03-31 $1.73B $0.19B 10.69%
2018-12-31 $1.66B $0.17B 10.17%
2018-09-30 $1.63B $0.16B 10.02%
2018-06-30 $1.58B $0.15B 9.35%
2018-03-31 $1.55B $0.11B 6.92%
2017-12-31 $1.51B $0.10B 6.42%
2017-09-30 $1.46B $0.08B 5.61%
2017-06-30 $1.45B $0.07B 5.10%
2017-03-31 $1.44B $0.09B 6.48%
2016-12-31 $1.42B $0.08B 5.56%
2016-09-30 $1.41B $0.08B 5.74%
2016-06-30 $1.37B $0.08B 6.04%
2016-03-31 $1.33B $0.00B 0.30%
2015-12-31 $1.28B $0.01B 0.94%
2015-09-30 $1.24B $0.01B 0.97%
2015-06-30 $1.22B $0.01B 0.90%
2015-03-31 $1.21B $0.09B 7.12%
2014-12-31 $1.21B $0.05B 4.40%
2014-09-30 $1.21B $0.03B 2.49%
2014-06-30 $1.21B $-0.14B -11.42%
2014-03-31 $1.22B $-0.14B -11.65%
2013-12-31 $1.25B $-0.12B -9.37%
2013-09-30 $1.29B $-0.10B -7.37%
2013-06-30 $1.35B $0.08B 5.77%
2013-03-31 $1.40B $0.09B 6.29%
2012-12-31 $1.44B $0.10B 6.59%
2012-09-30 $1.42B $0.11B 7.55%
2012-06-30 $1.42B $0.11B 7.72%
2012-03-31 $1.43B $0.13B 9.38%
2011-12-31 $1.42B $0.15B 10.66%
2011-09-30 $1.46B $0.19B 12.69%
2011-06-30 $1.49B $0.20B 13.53%
2011-03-31 $1.55B $0.22B 14.03%
2010-12-31 $1.60B $0.25B 15.43%
2010-09-30 $1.62B $0.26B 16.09%
2010-06-30 $1.60B $0.28B 17.70%
2010-03-31 $1.56B $0.29B 18.33%
2009-12-31 $1.48B $0.27B 18.13%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.145B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.695B 16.22
DaVita (DVA) United States $12.150B 15.09
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00